Filing Details
- Accession Number:
- 0001209191-23-005554
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-30 18:40:57
- Reporting Period:
- 2023-01-26
- Accepted Time:
- 2023-01-30 18:40:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 25743 | Therapeuticsmd Inc. | TXMD | Pharmaceutical Preparations (2834) | 870233535 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1627810 | C Michael Donegan | 951 Yamato Road Suite 220 Boca Raton FL 33431 | Prin. Fin. And Acctg. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-01-26 | 2,400 | $0.00 | 10,010 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-01-26 | 2,400 | $0.00 | 12,410 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-01-26 | 1,140 | $0.00 | 13,550 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-01-26 | 1,648 | $5.08 | 11,902 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-27 | 49 | $5.09 | 11,853 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Stock Units | Disposition | 2023-01-26 | 2,400 | $0.00 | 2,400 | $0.00 |
| Common Stock | Performance Stock Units | Disposition | 2023-01-26 | 2,400 | $0.00 | 2,400 | $0.00 |
| Common Stock | Performance Stock Units | Disposition | 2023-01-26 | 1,140 | $0.00 | 1,140 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct |
Footnotes
- Each performance stock unit ("PSU") represents a contingent right to receive one share of issuer common stock upon settlement. On January 26, 2023, the reporting person received 5,940 shares of issuer common stock in settlement of performance stock units (PSUs).
- The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.01 through $5.17, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
- Vesting of the PSUs was accelerated in connection with the termination of the reporting person's employment agreement without "Good Cause".
Billionaire Hedge Funds
